Search
Oramed Pharmaceuticals Inc
ORMPAdd to Watchlist
4.600USD
-0.010-0.22%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
188.26MMarket Cap
1.72P/E TTM
Oramed Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
2.00M
--
EPS(YoY)
1.55
431.38%
Analyst Rating
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its current assets were 133.27M, with a year-on-year change of -6.95.
What are the total assets of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its total assets of Oramed Pharmaceuticals Inc were 230.86M, with a year-on-year change of 48.68.
What are the total liabilities of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Oramed Pharmaceuticals Inc were 31.12M, with a year-on-year change of 213.36.
What is the total equity of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its total equity of Oramed Pharmaceuticals Inc was 199.74M, with a year-on-year change of 37.43.
What is the net investment of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its net investment of Oramed Pharmaceuticals Inc was 5.44M, with a year-on-year change of -94.86.
What is the net financing of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its net financing of Oramed Pharmaceuticals Inc was -4.74M, with a year-on-year change of 90.89.
What is the Earnings Per Share (EPS) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.55, with a year-on-year change of 431.38.
What is the Return on Equity (ROE) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 37.02, with a year-on-year change of 401.16.
What is the Return on Assets (ROA) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 33.16, with a year-on-year change of 426.16.
What is the operating profit of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -15.09M, with a year-on-year change of -18.05.